SEC Form 4 · accession 0001464521-26-000135
Heartflow, Inc. · HTFL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Campbell Rogers
Officer — Chief Medical Officer
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 9:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001464521
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2026 | M | 9,219 | $19.00 | A | 95,678 | D | |
| Common Stock | Aug 17, 2026 | S | 9,219 | $41.23 | D | 86,459 | D | |
| Common Stock | holding | — | — | — | 22,615 | I | By Campbell Rogers 2019 Irrevocable Trust | |
| Common Stock | holding | — | — | — | 46,159 | I | By CR Asset Protection Trust of 2023 | |
| Common Stock | holding | — | — | — | 26,012 | I | By Spouse's Trust | |
| Common Stock | holding | — | — | — | 50,754 | I | By The Campbell Rogers Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $19.00 | Aug 17, 2026 | M | 9,219 | D | — | Aug 7, 2035 | Common Stock | 9,219 | 82,972 | D |
Explanation of responses
- F1The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
- F2The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.